Titre : Capacité vitale

Capacité vitale : Questions médicales fréquentes

Termes MeSH sélectionnés :

Extremities
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Capacité vitale : Questions médicales les plus fréquentes", "headline": "Capacité vitale : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Capacité vitale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-22", "dateModified": "2025-04-16", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Capacité vitale" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Capacité pulmonaire totale", "url": "https://questionsmedicales.fr/mesh/D014109", "about": { "@type": "MedicalCondition", "name": "Capacité pulmonaire totale", "code": { "@type": "MedicalCode", "code": "D014109", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G09.772.850" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Volume de réserve expiratoire", "alternateName": "Expiratory Reserve Volume", "url": "https://questionsmedicales.fr/mesh/D005105", "about": { "@type": "MedicalCondition", "name": "Volume de réserve expiratoire", "code": { "@type": "MedicalCode", "code": "D005105", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G09.772.850.970.360" } } }, { "@type": "MedicalWebPage", "name": "Capacité inspiratoire", "alternateName": "Inspiratory Capacity", "url": "https://questionsmedicales.fr/mesh/D007320", "about": { "@type": "MedicalCondition", "name": "Capacité inspiratoire", "code": { "@type": "MedicalCode", "code": "D007320", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G09.772.850.970.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Volume de réserve inspiratoire", "alternateName": "Inspiratory Reserve Volume", "url": "https://questionsmedicales.fr/mesh/D007321", "about": { "@type": "MedicalCondition", "name": "Volume de réserve inspiratoire", "code": { "@type": "MedicalCode", "code": "D007321", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G09.772.850.970.500.375" } } }, { "@type": "MedicalWebPage", "name": "Volume courant", "alternateName": "Tidal Volume", "url": "https://questionsmedicales.fr/mesh/D013990", "about": { "@type": "MedicalCondition", "name": "Volume courant", "code": { "@type": "MedicalCode", "code": "D013990", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G09.772.850.970.500.700" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Capacité vitale", "alternateName": "Vital Capacity", "code": { "@type": "MedicalCode", "code": "D014797", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Toby M Maher", "url": "https://questionsmedicales.fr/author/Toby%20M%20Maher", "affiliation": { "@type": "Organization", "name": "Keck School of Medicine, University of Southern California, Los Angeles, California, USA." } }, { "@type": "Person", "name": "Hyun Lee", "url": "https://questionsmedicales.fr/author/Hyun%20Lee", "affiliation": { "@type": "Organization", "name": "Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea." } }, { "@type": "Person", "name": "Hye Yun Park", "url": "https://questionsmedicales.fr/author/Hye%20Yun%20Park", "affiliation": { "@type": "Organization", "name": "Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea." } }, { "@type": "Person", "name": "Masato Kono", "url": "https://questionsmedicales.fr/author/Masato%20Kono", "affiliation": { "@type": "Organization", "name": "Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan. Electronic address: masato.k@sis.seirei.or.jp." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Dedifferentiated liposarcoma of the extremities: a Korean multi-center study of 107 cases.", "datePublished": "2024-10-10", "url": "https://questionsmedicales.fr/article/39390540", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12885-024-13021-y" } }, { "@type": "ScholarlyArticle", "name": "Prognostic Factors and Surgical Impact of Non-metastatic Conventional Chondrosarcoma of the Extremities.", "datePublished": "2023-10-24", "url": "https://questionsmedicales.fr/article/37875420", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/os.13916" } }, { "@type": "ScholarlyArticle", "name": "Neurovascular structures to avoid during musculoskeletal ultrasound-guided intervention in the extremities.", "datePublished": "2023-06-15", "url": "https://questionsmedicales.fr/article/37318586", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00256-023-04372-x" } }, { "@type": "ScholarlyArticle", "name": "Informal Family Caregiving of Patients with Diabetic Extremity Wounds: An Integrative Review.", "datePublished": "2022-08-02", "url": "https://questionsmedicales.fr/article/35919019", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/01939459221115694" } }, { "@type": "ScholarlyArticle", "name": "Acute Extremity Compartment Syndrome and (Regional): Anesthesia: The Monster Under the Bed.", "datePublished": "2022-08-02", "url": "https://questionsmedicales.fr/article/36049877", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.anclin.2022.06.001" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes physiologiques respiratoires et circulatoires", "item": "https://questionsmedicales.fr/mesh/D002943" }, { "@type": "ListItem", "position": 3, "name": "Phénomènes physiologiques respiratoires", "item": "https://questionsmedicales.fr/mesh/D012143" }, { "@type": "ListItem", "position": 4, "name": "Capacité pulmonaire totale", "item": "https://questionsmedicales.fr/mesh/D014109" }, { "@type": "ListItem", "position": 5, "name": "Capacité vitale", "item": "https://questionsmedicales.fr/mesh/D014797" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Capacité vitale - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Capacité vitale", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Capacité vitale", "description": "Comment évaluer la capacité vitale ?\nQuels tests complètent l'évaluation ?\nQuels sont les critères normaux de capacité vitale ?\nQuand suspecter une capacité vitale réduite ?\nQuels signes indiquent un problème pulmonaire ?", "url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Extremities&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Capacité vitale", "description": "Quels symptômes sont liés à une capacité vitale faible ?\nLa toux est-elle un symptôme associé ?\nComment la fatigue se manifeste-t-elle ?\nY a-t-il des signes d'alerte ?\nLes symptômes varient-ils selon l'âge ?", "url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Extremities&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Capacité vitale", "description": "Comment prévenir la réduction de la capacité vitale ?\nLes vaccinations sont-elles importantes ?\nQuel rôle joue l'exercice physique ?\nFaut-il éviter certaines expositions ?\nL'hydratation est-elle importante ?", "url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Extremities&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Capacité vitale", "description": "Quels traitements améliorent la capacité vitale ?\nLa physiothérapie est-elle utile ?\nLes médicaments peuvent-ils aider ?\nQuand envisager une intervention chirurgicale ?\nLes traitements varient-ils selon la cause ?", "url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Extremities&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Capacité vitale", "description": "Quelles complications peuvent survenir ?\nLa capacité vitale faible augmente-t-elle les risques ?\nLes maladies cardiaques sont-elles liées ?\nComment les infections affectent-elles la capacité vitale ?\nY a-t-il des effets à long terme ?", "url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Extremities&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Capacité vitale", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il la capacité vitale ?\nLes maladies chroniques sont-elles un facteur ?\nLe sexe joue-t-il un rôle ?\nL'environnement de travail est-il un facteur ?", "url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Extremities&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer la capacité vitale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "La capacité vitale est mesurée par spirométrie, un test de la fonction pulmonaire." } }, { "@type": "Question", "name": "Quels tests complètent l'évaluation ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme la pléthysmographie et les gaz du sang peuvent être utilisés." } }, { "@type": "Question", "name": "Quels sont les critères normaux de capacité vitale ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les valeurs normales varient selon l'âge, le sexe et la taille, généralement entre 3 et 6 L." } }, { "@type": "Question", "name": "Quand suspecter une capacité vitale réduite ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Une capacité vitale réduite est suspectée en cas de dyspnée ou d'antécédents de maladies pulmonaires." } }, { "@type": "Question", "name": "Quels signes indiquent un problème pulmonaire ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme la toux persistante ou la fatigue peuvent indiquer une capacité vitale altérée." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une capacité vitale faible ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent essoufflement, fatigue, et sensation d'oppression thoracique." } }, { "@type": "Question", "name": "La toux est-elle un symptôme associé ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une toux persistante peut accompagner une capacité vitale diminuée." } }, { "@type": "Question", "name": "Comment la fatigue se manifeste-t-elle ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "La fatigue peut se manifester par une diminution de l'énergie et des difficultés à l'effort." } }, { "@type": "Question", "name": "Y a-t-il des signes d'alerte ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des douleurs thoraciques ou une cyanose nécessitent une attention médicale immédiate." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées en raison de la dégradation pulmonaire." } }, { "@type": "Question", "name": "Comment prévenir la réduction de la capacité vitale ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabagisme, pratiquer une activité physique régulière et avoir une alimentation équilibrée." } }, { "@type": "Question", "name": "Les vaccinations sont-elles importantes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccins contre la grippe et le pneumocoque aident à prévenir les infections respiratoires." } }, { "@type": "Question", "name": "Quel rôle joue l'exercice physique ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "L'exercice régulier améliore la fonction pulmonaire et la capacité vitale." } }, { "@type": "Question", "name": "Faut-il éviter certaines expositions ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, éviter les polluants et les allergènes peut aider à préserver la santé pulmonaire." } }, { "@type": "Question", "name": "L'hydratation est-elle importante ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une bonne hydratation aide à maintenir la santé des voies respiratoires." } }, { "@type": "Question", "name": "Quels traitements améliorent la capacité vitale ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la réhabilitation pulmonaire, les bronchodilatateurs et les corticostéroïdes." } }, { "@type": "Question", "name": "La physiothérapie est-elle utile ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la physiothérapie respiratoire aide à améliorer la capacité vitale et la fonction pulmonaire." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les bronchodilatateurs peuvent aider à ouvrir les voies respiratoires." } }, { "@type": "Question", "name": "Quand envisager une intervention chirurgicale ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une chirurgie peut être envisagée en cas de maladies pulmonaires graves, comme la BPCO." } }, { "@type": "Question", "name": "Les traitements varient-ils selon la cause ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le traitement dépend de la cause sous-jacente de la réduction de la capacité vitale." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent l'insuffisance respiratoire et des infections pulmonaires." } }, { "@type": "Question", "name": "La capacité vitale faible augmente-t-elle les risques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une capacité vitale faible augmente le risque de complications respiratoires graves." } }, { "@type": "Question", "name": "Les maladies cardiaques sont-elles liées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une capacité vitale réduite peut être associée à un risque accru de maladies cardiaques." } }, { "@type": "Question", "name": "Comment les infections affectent-elles la capacité vitale ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les infections pulmonaires peuvent réduire la capacité vitale en provoquant une inflammation." } }, { "@type": "Question", "name": "Y a-t-il des effets à long terme ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une capacité vitale réduite peut entraîner des effets à long terme sur la santé respiratoire." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent le tabagisme, l'exposition à des polluants et des antécédents familiaux." } }, { "@type": "Question", "name": "L'âge influence-t-il la capacité vitale ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la capacité vitale diminue généralement avec l'âge en raison de la dégradation pulmonaire." } }, { "@type": "Question", "name": "Les maladies chroniques sont-elles un facteur ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme l'asthme ou la BPCO augmentent le risque de capacité vitale réduite." } }, { "@type": "Question", "name": "Le sexe joue-t-il un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les hommes ont généralement une capacité vitale plus élevée que les femmes en moyenne." } }, { "@type": "Question", "name": "L'environnement de travail est-il un facteur ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, travailler dans des environnements pollués ou dangereux peut affecter la capacité vitale." } } ] } ] }

Sources (6780 au total)

Dedifferentiated liposarcoma of the extremities: a Korean multi-center study of 107 cases.

Dedifferentiated liposarcoma of the extremities (DDL-E) is rare in comparison to that of the retroperitoneum. Its clinical features and surgical principle for resection margins at the dedifferentiated... This retrospective multi-center study examined patients diagnosed with DDL-E from August 2004 to May 2023 at 5 sarcoma centers. Clinical features, oncologic outcomes, and prognostic factors were analy... A total of 107 patients were reviewed. The 5-year local recurrence free survival (LRFS), metastasis-free survival (MFS) and disease specific survival (DSS) were 84.7%, 78.6%, and 87.8%, respectively. ... This is the largest study examining DDL-E to-date. Localized DDL-E has low potential for metastasis and carries an excellent prognosis. Other primary malignancy and extrapulmonary metastasis are more ...

Prognostic Factors and Surgical Impact of Non-metastatic Conventional Chondrosarcoma of the Extremities.

Chondrosarcoma is a common bone malignancy, and the main treatment method is surgery. Different surgeries lead to different survival outcomes. The aim of this study was to construct a new clinical pre... A total of 620 patients with chondrosarcoma registered between January 1, 2000 and December 31, 2016 were recruited as study targets. The missing values are filled by multiple imputation. Two continuo... In a multivariate cox regression, age, grade, tumor size, radiotherapy, chemotherapy, and surgical methods were identified as independent prognostic factors for chondrosarcoma. To construct 1-, 3-, an... This study found that the 5 year overall survival rate of patients with non-metastatic chondrosarcoma of the extremities was about 80%. Age, high malignancy, large tumor, prior chemoradiotherapy, and ...

American Academy of Orthopaedic Surgeons/Major Extremity Trauma and Rehabilitation Consortium Appropriate Use Criteria: Pharmacologic, Physical, and Cognitive Pain Alleviation for Musculoskeletal Extremity/Pelvis Surgery.

The Major Extremity Trauma and Rehabilitation Consortium and the American Academy of Orthopaedic Surgeons developed an Appropriate Use Criteria (AUC) titled The Pharmacologic, Physical, and Cognitive ...

A Novel Surgical Classification for Extremity and Pelvic Hemophilic Pseudotumors: The PUMCH Classification.

A hemophilic pseudotumor (HPT) is a rare and challenging complication of hemophilia for which there is no classification system that provides uniformity of descriptions or that can be used to guide ma... The PUMCH (Peking Union Medical College Hospital) classification was developed on the basis of clinical manifestations and imaging features. Extremity and pelvic HPTs were divided into 4 types and 6 s... Forty-five patients with 53 HPTs that were treated at PUMCH between December 2005 and October 2021 were included. The mean age at the time of surgery was 35.4 ± 11.9 years, and the median follow-up du... The PUMCH classification is based on the anatomic pathology and surgical strategy for HPTs. The classification of HPTs corresponds to surgical outcomes, and may be helpful for decision-making regardin... Prognostic Level IV . See Instructions for Authors for a complete description of levels of evidence....

Timing and choice of systemic anticoagulation in the setting of extremity arterial injury repair.

The role of perioperative anticoagulation in the setting of peripheral arterial injury remains unclear. We hypothesized that early initiation of anticoagulation is associated with a reduced amputation... Using the 2016-2019 ACS-TQIP database, adult patients with upper and lower extremity vascular injuries who underwent open arterial repair and received anticoagulation were included. Patients were divi... 4379 patients were included, and 83.9% were males. 68.1% of patients received early anticoagulation, whereas 31.9% received late thromboprophylaxis. Low-molecular-weight heparin (LMWH) was used in 62.... Patients with the operative repair of arterial injuries receiving early perioperative anticoagulation demonstrated an improved limb salvage outcome than those who received late thromboprophylaxis. Our...

Prehospital tourniquet application in extremity vascular trauma: Improved functional outcomes.

Support for prehospital tourniquet use has increased, with recent data suggesting that tourniquet usage decreases shock without increasing limb complications. We hypothesized that prehospital tourniqu... We retrospectively studied adult patients with extremity vascular trauma at an urban civilian Level 1 trauma center (June 2016-May 2021). Outcomes of interest included delayed amputation and mobility ... Of 232 patients, prehospital tourniquet application was not associated with mortality or lactate level (both P > .05). The prehospital tourniquet application group had more transfusions, lower rates o... Prehospital tourniquet application was associated with favorable outcomes, including higher functional mobility and decreased delayed amputation. This suggests that tourniquet use should be encouraged...